DiaMedica Therapeutics (DMAC) Inventory (2021 - 2023)

DiaMedica Therapeutics (DMAC) has reported Inventory for 3 consecutive years, with $317000.0 the latest figure, recorded in Q4 2023.

• For the quarter ending Q4 2023, Inventory rose 654.76% year-over-year to $317000.0; the trailing twelve-month figure through Dec 2023 stood at $317000.0 (up 654.76% YoY), and the FY2023 full-year result was $317000.0, up 654.76% from the prior year.
• Inventory fell to $317000.0 in Q4 2023 per DMAC's latest filing, from $715000.0 in the prior quarter.
• Across five years, Inventory topped out at $715000.0 in Q3 2023 and bottomed at $42000.0 in Q4 2022.
• Historically, Inventory has averaged $223000.0 across 3 years, with a median of $102500.0 in 2021.
• The sharpest annual moves came in 2022 and 2023: Inventory sank 62.83% in 2022, then jumped 654.76% in 2023.
• Over 3 years, Inventory stood at $113000.0 in 2021, then tumbled by 62.83% to $42000.0 in 2022, then surged by 654.76% to $317000.0 in 2023.
• According to Business Quant data, Inventory over the past three periods registered $317000.0, $715000.0, and $59000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.